Status:
UNKNOWN
Dopamine in Neonate
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Asan Medical Center
Severance Hospital
Conditions:
Neonates and Preterm Infants
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of dopamine which is used as treatment of hypotension in neonate and preterm infant.
Eligibility Criteria
Inclusion
- Admitted at NICU in Seoul National University Hospital, Seoul Asan Hospital or Severance Hospital
- Infants who were diagnosed with hypotension
Exclusion
- Congenital heart disease
- Chromosomal anomaly
- Treated with ECMO or CRRT
- Arrhythmia
- Hypovolemic state
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04525495
Start Date
April 1 2020
End Date
December 31 2022
Last Update
August 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Children's Hospital
Seoul, South Korea, 110-744